Supplement “Pharmacogenetics in HIV infection” Volume 26, Supplement 6, May 2008
Pharmacogenetics of antiretroviral therapy 2008: toward personalized treatment?
Francesc Vidal Marsal Enferm Infecc Microbiol Clin. 2008;26 Supl 6:1-3 Conflict of interest: the author declares he has no conflict of interest.
General concepts and study methods in pharmacogenetics
Rubin Lubomirov, Amalio Telenti and Margalida Rotger Enferm Infecc Microbiol Clin. 2008;26 Supl 6:4-9 Conflict of interest: the authors declare they have no conflict of interest.
The pharmacogenetics of response to antiretroviral therapy
Sonia Rodríguez-Nóvoa and Vicente Soriano Vázquez Enferm Infecc Microbiol Clin. 2008;26 Supl 6:10-7 Conflict of interest: the authors declare they have no conflict of interest.
Toxicogenetics of antiretroviral treatment (I): Lipodystrophy, metabolic perturbations and atherosclerosis
M. del Mar Gutiérrez Maciá, M. Gracia Mateo García, Francesc Vidal Marsal and Pere Domingo Pedrol Enferm Infecc Microbiol Clin. 2008;26 Supl 6:18-23 Conflict of interest: the authors declare they have no conflict of interest.
Toxicogenetics of antiretroviral treatment (II): Neurotoxicity, hepatotoxicity, lactic acidosis, kidney damage, and other adverse effects of antiretroviral drugs
Victoria Sánchez Hellín and Félix Gutiérrez Rodero Enferm Infecc Microbiol Clin. 2008;26 Supl 6:24-33 Conflict of interest: the authors declare they have no conflict of interest.
HLA-B*5701 and hypersensitivity reactions to abacavir. Study methods and clinical relevance
Mireia Arnedo Valero Enferm Infecc Microbiol Clin. 2008;26 Supl 6:34-9 Conflict of interest: the author declares she has no conflict of interest.
Prospective validation of a pharmacogenetic test: the PREDICT-1 study
Rosa M. Muñoz de Benito and José Ramón Arribas López Enferm Infecc Microbiol Clin. 2008;26 Supl 6:40-4 Conflict of interest: Rosa M. Muñoz de Benito declares she has no conflict of interest. José Ramón Arribas López has declared he received payment as consultant, researcher and lecturer for GSK.
Applicability of pharmacogenetics studies in daily clinical practice
José Antonio Iribarren Loyarte Enferm Infecc Microbiol Clin. 2008;26 Supl 6:45-54 Conflict of interest: the author declares he has no conflict of interest.
